Multiple epiphyseal dysplasia-miniepiphyses syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:166032OMIM:609325Q77.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Multiple epiphyseal dysplasia with miniepiphyses (MED-miniepiphyses syndrome) is a rare skeletal disorder classified within the group of multiple epiphyseal dysplasias. It is characterized by the presence of abnormally small epiphyses (the rounded ends of long bones that contribute to joint formation) throughout the skeleton. This condition primarily affects the skeletal system, leading to joint pain, stiffness, and early-onset degenerative joint disease (osteoarthritis). Affected individuals typically present in childhood with difficulties in walking, a waddling gait, and short stature that may be mild to moderate in degree. The hallmark radiographic finding is the presence of unusually small, often irregularly shaped epiphyses at multiple joints, distinguishing this form from other types of multiple epiphyseal dysplasia where epiphyses may be flattened or fragmented rather than miniaturized. The hips, knees, and ankles are commonly involved, and hand radiographs may also show small epiphyses. Joint involvement can lead to progressive pain and limitation of movement, particularly in weight-bearing joints. There is currently no cure or disease-specific treatment for MED-miniepiphyses syndrome. Management is supportive and symptomatic, focusing on pain control, physical therapy to maintain joint mobility and muscle strength, and orthopedic interventions as needed. Joint replacement surgery may be considered in cases of severe degenerative arthritis. Regular monitoring by orthopedic and genetic specialists is recommended to manage complications and optimize quality of life.

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Multiple epiphyseal dysplasia-miniepiphyses syndrome.

View clinical trials →

No actively recruiting trials found for Multiple epiphyseal dysplasia-miniepiphyses syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Multiple epiphyseal dysplasia-miniepiphyses syndrome community →

No specialists are currently listed for Multiple epiphyseal dysplasia-miniepiphyses syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Multiple epiphyseal dysplasia-miniepiphyses syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Multiple epiphyseal dysplasia-miniepiphyses syndromeForum →

No community posts yet. Be the first to share your experience with Multiple epiphyseal dysplasia-miniepiphyses syndrome.

Start the conversation →

Latest news about Multiple epiphyseal dysplasia-miniepiphyses syndrome

No recent news articles for Multiple epiphyseal dysplasia-miniepiphyses syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Multiple epiphyseal dysplasia-miniepiphyses syndrome

What is Multiple epiphyseal dysplasia-miniepiphyses syndrome?

Multiple epiphyseal dysplasia with miniepiphyses (MED-miniepiphyses syndrome) is a rare skeletal disorder classified within the group of multiple epiphyseal dysplasias. It is characterized by the presence of abnormally small epiphyses (the rounded ends of long bones that contribute to joint formation) throughout the skeleton. This condition primarily affects the skeletal system, leading to joint pain, stiffness, and early-onset degenerative joint disease (osteoarthritis). Affected individuals typically present in childhood with difficulties in walking, a waddling gait, and short stature that m

How is Multiple epiphyseal dysplasia-miniepiphyses syndrome inherited?

Multiple epiphyseal dysplasia-miniepiphyses syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Multiple epiphyseal dysplasia-miniepiphyses syndrome typically begin?

Typical onset of Multiple epiphyseal dysplasia-miniepiphyses syndrome is childhood. Age of onset can vary across affected individuals.